Is Healthy Life overvalued or undervalued?

As of 14 August 2025, Healthy Life's valuation grade has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, especially when compared to its peers in the FMCG sector. Key ratios include a PE ratio of 42.33, an EV to EBITDA of 28.66, and a ROCE of 16.28%.
In comparison to its peers, Healthy Life's PE ratio is significantly lower than Hindustan Unilever's 54.86 and Nestle India's 69.82, both of which are categorized as very expensive. This suggests that Healthy Life offers a more favorable valuation relative to these competitors. Additionally, while Healthy Life has experienced a year-to-date decline of 32.65%, it has outperformed the Sensex with a one-year return of 40.39%, reinforcing its attractiveness in the market.